Literature DB >> 1901779

Selective deficiency of interferon-gamma production in the hyper-IgE syndrome. Relationship to in vitro IgE synthesis.

R Paganelli1, E Scala, M R Capobianchi, E Fanales-Belasio, G D'Offizi, M Fiorilli, F Aiuti.   

Abstract

We measured the in vitro production of interferon-gamma (IFN-gamma) in five cases of hyper-IgE syndrome (HIgE), induced by mitogens, calcium ionophores and phorbol ester. The biosynthesis of IFN-gamma was severely reduced or undetectable in HIgE, while it was near normal in most atopic patients. The in vitro spontaneous production of IgE was increased overall in HIgE patients, although no correlation was found with serum IgE levels. Recombinant interleukin-4 (IL-4) induced a further increase in IgE synthesis, and its effect was totally antagonized by recombinant IFN-gamma; the same pattern of response was also observed in atopic subjects with high production of IgE. IFN-alpha synergized with IL-4 on IgE synthesis, whereas recombinant IL-6 gave opposite changes in individual cases tested. We propose that IFN-gamma deficiency may be responsible for some of the features of HIgE patients, including IgE levels and infections.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1901779      PMCID: PMC1535351     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  29 in total

1.  Recombinant gamma interferon in treatment of patients with atopic dermatitis and elevated IgE levels.

Authors:  M Boguniewicz; H S Jaffe; A Izu; M J Sullivan; D York; R S Geha; D Y Leung
Journal:  Am J Med       Date:  1990-04       Impact factor: 4.965

2.  Evidence that defective interferon-gamma production in atopic dermatitis patients is due to intrinsic abnormalities.

Authors:  U Reinhold; W Wehrmann; S Kukel; H W Kreysel
Journal:  Clin Exp Immunol       Date:  1990-03       Impact factor: 4.330

Review 3.  Abnormalities in the regulation of human IgE synthesis.

Authors:  R H Buckley; W G Becker
Journal:  Immunol Rev       Date:  1978       Impact factor: 12.988

4.  IgE antibodies to Staphylococcus aureus and Candida albicans in patients with the syndrome of hyperimmunoglobulin E and recurrent infections.

Authors:  M Berger; C H Kirkpatrick; P K Goldsmith; J I Gallin
Journal:  J Immunol       Date:  1980-12       Impact factor: 5.422

5.  IgE production in vitro by human blood mononuclear cells: a comparison between atopic and nonatopic subjects.

Authors:  Z Hemady; F Blomberg; S Gellis; R E Rocklin
Journal:  J Allergy Clin Immunol       Date:  1983-03       Impact factor: 10.793

6.  Abnormal humoral immune response to Staphylococcus aureus in patients with Staphylococcus aureus hyper IgE syndrome.

Authors:  L Matter; J A Wilhelm; F Roth; K Schopfer
Journal:  Clin Exp Immunol       Date:  1986-11       Impact factor: 4.330

7.  In vitro synthesis of human IgE: reappraisal of a 5-year study.

Authors:  M Ricci; G F Del Prete; E Maggi; A Lanzavecchia; P G Sala; S Romagnani
Journal:  Int Arch Allergy Appl Immunol       Date:  1985

8.  Circulating IgG autoantibodies to IgE in atopic syndromes.

Authors:  I Quinti; C Brozek; N Wood; R S Geha; D Y Leung
Journal:  J Allergy Clin Immunol       Date:  1986-04       Impact factor: 10.793

Review 9.  The hyperimmunoglobulin E recurrent-infection (Job's) syndrome. A review of the NIH experience and the literature.

Authors:  H Donabedian; J I Gallin
Journal:  Medicine (Baltimore)       Date:  1983-07       Impact factor: 1.889

10.  Interleukin 2-mediated immune interferon (IFN-gamma) production by human T cells and T cell subsets.

Authors:  T Kasahara; J J Hooks; S F Dougherty; J J Oppenheim
Journal:  J Immunol       Date:  1983-04       Impact factor: 5.422

View more
  8 in total

1.  Collaborative Interferon-γ and Interleukin-17 Signaling Protects the Oral Mucosa from Staphylococcus aureus.

Authors:  Jobert G Barin; Monica V Talor; Julie A Schaub; Nicola L Diny; Xuezhou Hou; Matthew Hoyer; Nathan K Archer; Elizabeth S Gebremariam; Meghan F Davis; Lloyd S Miller; Noel R Rose; Daniela Čiháková
Journal:  Am J Pathol       Date:  2016-07-26       Impact factor: 4.307

Review 2.  Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases.

Authors:  D R Lucey; M Clerici; G M Shearer
Journal:  Clin Microbiol Rev       Date:  1996-10       Impact factor: 26.132

3.  Genetic linkage of hyper-IgE syndrome to chromosome 4.

Authors:  B Grimbacher; A A Schäffer; S M Holland; J Davis; J I Gallin; H L Malech; T P Atkinson; B H Belohradsky; R H Buckley; F Cossu; T Español; B Z Garty; N Matamoros; L A Myers; R P Nelson; H D Ochs; E D Renner; N Wellinghausen; J M Puck
Journal:  Am J Hum Genet       Date:  1999-09       Impact factor: 11.025

4.  Allergen-stimulated interleukin-4 and interferon-gamma production in primary culture: responses of subjects with allergic rhinitis and normal controls.

Authors:  M Imada; F E Simons; F T Jay; K T Hayglass
Journal:  Immunology       Date:  1995-07       Impact factor: 7.397

5.  IgE production in atopic patients is not related to IL-4 production.

Authors:  C T van der Pouw Kraan; R C Aalberse; L A Aarden
Journal:  Clin Exp Immunol       Date:  1994-08       Impact factor: 4.330

6.  Hyper-response of serum IgG1 to Staphylococcus aureus peptidoglycan in patients with hyper-IgE syndrome.

Authors:  A Ishizaka; K Kojima; Y Sakiyama; S Matsumoto; K Kuwajima; Y Wagatsuma; R Shibata; K Joh
Journal:  Clin Exp Immunol       Date:  1992-01       Impact factor: 4.330

Review 7.  The hyper-IgE syndrome.

Authors:  R H Buckley
Journal:  Clin Rev Allergy Immunol       Date:  2001-02       Impact factor: 10.817

8.  CD8+ T lymphocytes provide helper activity for IgE synthesis in human immunodeficiency virus-infected patients with hyper-IgE.

Authors:  R Paganelli; E Scala; I J Ansotegui; C M Ausiello; E Halapi; E Fanales-Belasio; G D'Offizi; I Mezzaroma; F Pandolfi; M Fiorilli; A Cassone; F Aiuti
Journal:  J Exp Med       Date:  1995-01-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.